Table of contents:

Report methodology

Executive summary

Overview of the in-vitro diagnostics market in Poland

• Key events and trends in the in-vitro diagnostics market in 2007-2009
• Expected trends and developments in 2010-2012
• The value of the IVD market in 2004-2
• and the IVD market summary
• Foreign trade
• Blood-grouping reagents
• Opacifying preparations for x-ray examinations; diagnostic reagents for administration to patients

Analysis of individual segments of the IVD market

• Clinical chemistry
• Products for diabetics
• Immunology and immunochemistry
• Haematology, histology and cytology
• Microbiology
• Molecular diagnostics

Key players in the IVD market in Poland

• Key Polish players in the IVD market

Medical diagnostic laboratories

• Market overview
• The number and type of laboratories
• The location of laboratories
• Profiles of selected top market players
• Legal environment

Legal aspects

• Key legislation
• The Act on Medical Devices
• Reimbursement aspect
• Specialist medical supplies shops

Demographic and epidemiological trends

• Demographic trends
• Epidemilogical trends and disease diagnostics
• Cardiovascular diseases
• Neoplasms
• Infectious diseases

List of graphs

List of tables

About PMR

Contact PMR

List of graphs and Tables:

List of graphs

1. The value (PLN m) and change of the IVD market in Poland, 2004-2012
2. Debt due from independent public healthcare centres in Poland (PLN bn), Q1 2005-Q3 2009
3. Total debt of independent healthcare centres in Poland (PLN bn), Q1 2005-Q3 2009
4. Frequency of tests for cholesterol, PSA and FOBT in Poland compared to the EU average, 2006
5. Distribution of spending by healthcare sector in Poland, 2004-2012
6. The value (PLN bn) and change of the private healthcare market in Poland, 2005-2011
7. The value (PLN m) and change of the IVD market in Poland, 2004-2012
8. Imports of blood-grouping reagents (PLN m) to Poland and imports growth, 2004-H1 2009
9. Imports of blood-grouping reagents to Poland, by country, 2008
10. Imports of blood-grouping reagents to Poland, by country, H1 2009
11. Imports of opacifying preparations for x-ray examinations and diagnostic reagents for administration to patients (PLN m) to Poland and imports growth, 2004-H1 2009
12. Imports of opacifying preparations for x-ray examinations and diagnostic reagents for administration to patients to Poland, by country, 2008
13. Imports of opacifying preparations for x-ray examinations and diagnostic reagents for administration to patients to Poland, by country, H1 2009
14. Exports of opacifying preparations for x-ray examinations and diagnostic reagents for administration to patients (PLN m) from Poland and exports growth, 2004-H1 2009
15. Exports of opacifying preparations for x-ray examinations and diagnostic reagents for administration to patients from Poland, by country, 2008
16. Exports of opacifying preparations for x-ray examinations and diagnostic reagents for administration to patients from Poland, by country, H1 2009
17. Shares of the Polish IVD market sectors by value, 2008
18. Operating segments of the IVD market in Poland by value, 2008
19. The value (PLN m) and growth of the clinical chemistry segment of the IVD market in Poland, 2005-2008
20. The value structure of sales of reagents used in clinical chemistry in Poland, 2008
21. The growth in the value of sales of individual segments of reagents used in clinical chemistry in Poland, 2008
22. The value (PLN m) and growth of the segment of diabetic tests and products for diabetics of the IVD market in Poland, 2005-2008
23. The value structure of sales of reagents used in immunochemistry and immunology in Poland, 2008
24. The value structure of sales of reagents used in infectious immunology in Poland, 2008
25. The growth in the value of sales of individual segments of reagents used in immunochemistry and immunology in Poland, 2008
26. The growth in the value of sales of individual segments of reagents used in infectious immunology in Poland, 2008
27. The value (PLN m) and growth of the immunology and immunochemistry segment of the IVD market in Poland, 2005-2008
28. The value structure of sales of instruments used in chemistry and immunochemistry and sales growth in Poland, 2008
29. The value (PLN m) and growth of the haematology, histology and cytology segment of the IVD market in Poland, 2005-2008
30. The value structure of sales of reagents used in haematology, histology and cytology and sales growth in Poland, 2008
31. The value structure of sales of instruments used in haematology, histology and cytology and sales growth in Poland, 2008
32. The value (PLN m) and growth of the microbiology segment of the IVD market in Poland in 2005-2008
33. The value structure of sales of reagents used in microbiology and sales growth in Poland, 2008
34. The value (PLN m) and growth of the molecular segment of the IVD market in Poland, 2005-2008
35. Revenue of Roche Diagnostics (PLN m) and revenue growth in Poland, 2004-2008
36. Net profit of Roche Diagnostics (PLN m) and net profit change in Poland, 2004-2008
37. Contribution of the Polish division to global revenue of Roche Diagnostics, 2003-2008
38. Revenue of Abbott (PLN m) and revenue change in Poland, 2004-2008
39. Net profit of Abbott (PLN m) and net profit change in Poland, 2004-2007
40. Revenue of bioMerieux (PLN m) and revenue growth in Poland, 2003-2008
41. Net profit (PLN m) of bioMerieux and net profit change in Poland, 2003-2008
42. Sales revenue by type and y-o-y change by business segments of bioMerieux in Poland, 2009
43. Contribution of the Polish division to global revenue of bioMerieux, 2003-2008
44. Revenue of Siemens Healthcare Diagnostics (PLN m) and revenue growth in Poland, 2007-2009
45. Net financial result of Siemens Healthcare Diagnostics (PLN m) in Poland, 2007-2008
46. Contribution of the Polish division to global revenue of Siemens Healthcare Diagnostics, 2007-2008
47. Revenue of Johnson & Johnson (PLN m) and revenue growth in Poland, 2004-2007
48. Revenue of Comesa (PLN m) and revenue growth in Poland, 2004-2008
49. Net profit of Comesa (PLN m) and net profit growth in Poland, 2004-2008
50. Revenue of Becton Dickinson (PLN m) and revenue change in Poland, 2003-2008
51. Net profit of Becton Dickinson (PLN m) and net profit change in Poland, 2003-2008
52. Revenue of Sysmex (PLN m) and revenue growth in Poland, 2005-2009
53. Net profit of Sysmex (PLN m) and net profit growth in Poland, 2005-2009
54. Revenue of Biomedica (PLN m) and revenue growth in Poland, 2004-2008
55. Net profit (loss) of Biomedica (PLN m) in Poland, 2004-2008
56. Revenue of Genexo (PLN m) and revenue change in Poland, 2004-2007
57. Net profit (loss) of Genexo (PLN m) in Poland, 2003-2007
58. Revenue from domestic sales (PLN m) of PZ Cormay and revenue change, 2004-Q3 2009
59. Revenue from export sales (PLN m) of PZ Cormay and revenue change, 2004-Q3 2009
60. Net profit of PZ Cormay (PLN m) and net profit change, 2004-Q3 2009
61. Sales revenue by type and sales growth by business segments of PZ Cormay, Q1-Q3 2009
62. Structure of PZ Cormay’s revenue by operating segment, Q1-Q3 2009
63. Revenue of Hand-Prod (PLN m) and revenue change in Poland, 2005-2006
64. Revenue of Transfarm (PLN m) and revenue change in Poland, 2003-2008
65. Net profit of Transfarm (PLN m) and net profit change in Poland, 2003-2008
66. Revenue of Emapol (PLN m) and revenue change in Poland, 2003-2008
67. Net profit of Emapol (PLN m) and net profit change in Poland, 2003-2008
68. Revenue of Bio-Ksel (PLN m) and revenue growth in Poland, 2003-2008
69. Net profit of Bio-Ksel (PLN m) and net profit change in Poland, 2006-2008
70. Revenue of Pro Scientium (PLN m) and revenue change in Poland, 2004-2006
71. Net profit (loss) of Pro Scientium (PLN m) in Poland, 2004-2006
72. Power configuration (PLN m) on the IVD market in Poland, 2004-2008
73. Public and non-public healthcare facilities performing laboratory tests in Poland, December 2009
74. The number of healthcare facilities performing laboratory tests in Poland, by voivodship, December 2009
75. The number of entities of healthcare facilities performing laboratory tests in Poland, by voivodship, December 2009
76. The number of entities of healthcare facilities performing laboratory tests in Poland (per 10,000 residents), by voivodship, December 2009
77. Revenue and net profit of Diagnostyka (PLN m) in Poland, 2003-2007
78. The location of Diagnostyka’s laboratories in Poland (the number of laboratories), December 2009
79. Revenue and net profit (PLN m) of Synevo Polska, 2005-2007
80. The location of Synevo’s laboratories in Poland (the number of laboratories), December 2009
81. The location of Alpha Medical’s laboratories in Poland (the number of laboratories), December 2009
82. The location of Medical Laboratories Fryda in Poland (the number of laboratories), December 2009
83. Poland’s population (million), 2004-2035
84. Population forecast for selected age groups in Poland (million), 2004-2035
85. Life expectancy at birth in Poland (years), 1990-2035
86. Deaths caused by cardiovascular diseases, by type of disease, Poland, 2006

List of tables

1. Top 10 players on the Polish IVD market, 2007 and 2008
2. The number of diagnostic laboratories by type in Poland, November 2009
3. The list of diagnostic tests ordered and financed by primary care doctors, which are required when offering primary healthcare benefits in Poland, 2009
4. Specialist medical supplies shops in Poland, 2008

Download white paper: